In all 4 cases, enhanced lymphocyte infiltration was observed when PBMC where incubated with tumor cell supernatant of cetuximab treated IFNγ/TNFα stimulated cancer cells (Fig 1C). The gene discussed is IFNG; the disease is cancer.